BioSpace News Archive

CSI to Commercialize Product upon Successful Manufacturing Transfer

Innovent Biologics, Inc. announced the signing of a collaboration agreement with Shenogen Pharma Group Ltd. to evaluate the combination therapy of Innovent’s Tyvyt®, a fully human anti-programmed cell death protein 1 monoclonal antibody with Shenogen’s SNG1005, in patients with advanced cancer.

Company co-founders will drive across the country this summer to thank 100 communities in person

Industry veteran joins at time of rapid growth for cloud-based enterprise application platform

Qosina carries a unique selection of open-bore syringes that are ideal for applications involving viscous substances.

Infusion Express, a patient-focused operator of ambulatory infusion centers, today announced completion of a new round of funding of $22.5M to accelerate its nationwide expansion.

Paralyzed Veterans of America seeks court order to advance protections for veterans with mobility impairments and the entire disability community

Lenus Therapeutics, LLC (the ‘Company’), a US-based joint venture between GtreeBNT (‘Gtree’) and Yuyang DNU (‘Yuyang’) in Korea, announced that it has confirmed complete wound healing of the index lesion of the first subject enrolled in its ongoing single-masked Phase 2 clinical trial with RGN-137 dermal gel for Epidermolysis Bullosa (EB).

Evofem Biosciences, Inc., a clinical-stage biopharmaceutical company, reported additional data from its Phase 3 ‘AMPOWER’ clinical trial of Amphora® for the prevention of pregnancy.

Study will assess full PK profile and PD effect on target pathways and metabolic parameters in parallel with the ongoing Phase 2a efficacy and safety study